How AbbVie accelerates drug discovery with Claude

Sarah Nam, VP of AI Strategy and Partnerships at AbbVie, and Anthropic’s Ivy Weng discuss how AbbVie is transforming pharmaceutical research and development with AI. Sarah shares how AbbVie uses Claude for Life Sciences to reimagine drug discovery, from analyzing multimodal biological data to optimizing clinical trials with smarter patient stratification and adaptive protocols. They also explore AbbVie’s approach to bringing AI skills to employees across the entire company. Learn more about what Claude can do for life sciences: https://claude.com/solutions/life-sciences

Sarah NamguestIvy Wenghost

Oct 20, 202510mWatch on YouTube ↗

EPISODE INFO

Released: October 20, 2025
Duration: 10m
Channel: Anthropic
Watch on YouTube: ▶ Open ↗

EPISODE DESCRIPTION

Sarah Nam, VP of AI Strategy and Partnerships at AbbVie, and Anthropic’s Ivy Weng discuss how AbbVie is transforming pharmaceutical research and development with AI. Sarah shares how AbbVie uses Claude for Life Sciences to reimagine drug discovery, from analyzing multimodal biological data to optimizing clinical trials with smarter patient stratification and adaptive protocols. They also explore AbbVie’s approach to bringing AI skills to employees across the entire company. Learn more about what Claude can do for life sciences: https://claude.com/solutions/life-sciences

SPEAKERS

Sarah Nam
guest
Vice President of AI Strategy and Partnerships at AbbVie.
Ivy Weng
host
Healthcare and life sciences go-to-market team member at Anthropic.

EPISODE SUMMARY

In this episode of Anthropic, featuring Sarah Nam and Ivy Weng, How AbbVie accelerates drug discovery with Claude explores abbVie uses Claude to transform pharma workflows and drug discovery AbbVie is pursuing a value-chain AI strategy that targets priorities across discovery, development, and commercial functions to improve patient impact and operational performance.

RELATED EPISODES